Retrosternal Scarpulla et al. () Retrospective 83 patients (complete 4-day Inclusion: Index test: discomfort case series recordings were available for 34/83) Gastroenterology Not stated System: Bravo™ wireless capsule system Division, M. Level: IV 44 females, 39 males Exclusion: Insertion: not stated Raimondi Quality: Q2 Median age: 42 years (range 18–63) Not stated Placement: 6 cm above the Z line Hospital, Can CX Indications: Cataldo, Italy Duration: 24, 48, 72 and/or 96 hours Typical reflux symptoms or atypical P2 Comparator: NA symptoms including chest pain and extra oesophageal complaints Throat discomfort Schneider et al. () Non-randomised 123 patients Inclusion: Index test: Oesophageal controlled trial Department of Bravo group: 36 males and 32 Not stated System: Bravo™ wireless capsule system discomfort General, Visceral, females, mean age: 51 years (range Exclusion: Insertion: transorally Limitation in daily and Transplant 34–67) Level: III-2 activities Not stated Placement: 5 cm above the upper border of Surgery, Catheter group: 29 males and 26 Quality: 9/26 the LOS University females, mean age 43 years (range Hospital of CX Duration: 48 hours 32–59) Tubingen, P3 Comparator: Tubingen, Germany System: not stated Insertion: transnasally Placement: not stated Duration: 24 hours Capsule Shahid & Fisher Case report 1 patient Inclusion: Index test dislodgement in the () 61 year old female NA System: Bravo™ wireless capsule system left mainstem Gastroenterology, bronchus Indication: Exclusion: Insertion: transorally Section, Temple History of heartburn, regurgitation NA Placement: not stated University and intermittent chest pain, Hospital, Comparator: NA unresponsive to PPI therapy Philadelphia, Pennsylvania, USA
Scarpulla et al. () Gastroenterology Division, M. Raimondi Hospital, Can Cataldo, Italy Retrospective case series Level: IV Quality: Q2 CX P2 83 patients (complete 4-day recordings were available for 34/83) 44 females, 39 males Median age: 42 years (range 18–63) Indications: Typical reflux symptoms or atypical symptoms including chest pain and extra oesophageal complaints Inclusion: Not stated Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: not stated Placement: 6 cm above the Z line Duration: 24, 48, 72 and/or 96 hours Comparator: NA Retrosternal discomfort Schneider et al. () Department of General, Visceral, and Transplant Surgery, University Hospital of Tubingen, Tubingen, Germany Non-randomised controlled trial Level: III-2 Quality: 9/26 CX P3 123 patients Bravo group: 36 males and 32 females, mean age: 51 years (range 34–67) Catheter group: 29 males and 26 females, mean age 43 years (range 32–59) Inclusion: Not stated Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: transorally Placement: 5 cm above the upper border of the LOS Duration: 48 hours Comparator: System: not stated Insertion: transnasally Placement: not stated Duration: 24 hours Throat discomfort Oesophageal discomfort Limitation in daily activities Shahid & Fisher () Gastroenterology, Section, Temple University Hospital, Philadelphia, Pennsylvania, USA Case report 1 patient 61 year old female Indication: History of heartburn, regurgitation and intermittent chest pain, unresponsive to PPI therapy Inclusion: NA Exclusion: NA Index test System: Bravo™ wireless capsule system Insertion: transorally Placement: not stated Comparator: NA Capsule dislodgement in the left mainstem bronchus